Found: 108
Select item for more details and to access through your institution.
Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 12, p. 5669, doi. 10.1111/dom.15935
- By:
- Publication type:
- Article
Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 18, p. 2363, doi. 10.1001/jama.289.18.2363
- By:
- Publication type:
- Article
South African Hypertension Society 2012 congress report.
- Published in:
- Cardiovascular Journal of Africa, 2012, v. 23, n. 3, p. 172
- By:
- Publication type:
- Article
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
- Published in:
- Kidney International, 2013, v. 83, n. 3, p. 517, doi. 10.1038/ki.2012.401
- By:
- Publication type:
- Article
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus.
- Published in:
- Kidney International, 2013, v. 83, n. 2, p. 278, doi. 10.1038/ki.2012.383
- By:
- Publication type:
- Article
High prevalence of non-dipping patterns among Black Africans with uncontrolled hypertension: a secondary analysis of the CREOLE trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control.
- Published in:
- Diabetologia, 2021, v. 64, n. 9, p. 2012, doi. 10.1007/s00125-021-05491-7
- By:
- Publication type:
- Article
Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study.
- Published in:
- Diabetologia, 2020, v. 63, n. 8, p. 1637, doi. 10.1007/s00125-020-05162-z
- By:
- Publication type:
- Article
Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.
- Published in:
- Diabetologia, 2018, v. 61, n. 7, p. 1581, doi. 10.1007/s00125-018-4619-x
- By:
- Publication type:
- Article
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality.
- Published in:
- Diabetologia, 2018, v. 61, n. 1, p. 58, doi. 10.1007/s00125-017-4422-0
- By:
- Publication type:
- Article
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
- Published in:
- Diabetologia, 2018, v. 61, n. 1, p. 48, doi. 10.1007/s00125-017-4423-z
- By:
- Publication type:
- Article
Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.
- Published in:
- Diabetologia, 2016, v. 59, n. 12, p. 2603, doi. 10.1007/s00125-016-4082-5
- By:
- Publication type:
- Article
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes.
- Published in:
- Diabetologia, 2014, v. 57, n. 12, p. 2465, doi. 10.1007/s00125-014-3369-7
- By:
- Publication type:
- Article
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 7, p. 1932, doi. 10.1111/dom.15058
- By:
- Publication type:
- Article
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1420, doi. 10.1111/dom.14351
- By:
- Publication type:
- Article
The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1292, doi. 10.1111/dom.14339
- By:
- Publication type:
- Article
Development of a hypoglycaemia risk score to identify high‐risk individuals with advanced type 2 diabetes in DEVOTE.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2248, doi. 10.1111/dom.14208
- By:
- Publication type:
- Article
Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2241, doi. 10.1111/dom.14049
- By:
- Publication type:
- Article
Sex‐specific associations between cardiovascular risk factors and myocardial infarction in patients with type 2 diabetes: The ADVANCE‐ON study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1818, doi. 10.1111/dom.14103
- By:
- Publication type:
- Article
Long‐term efficacy and safety of combined insulin and glucagon‐like peptide‐1 therapy: Evidence from the LEADER trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2450, doi. 10.1111/dom.13826
- By:
- Publication type:
- Article
Fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1506, doi. 10.1111/dom.13675
- By:
- Publication type:
- Article
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1437, doi. 10.1111/dom.13677
- By:
- Publication type:
- Article
Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1903, doi. 10.1111/dom.13311
- By:
- Publication type:
- Article
Control of Blood Pressure and Risk Attenuation: Post Trial Follow-Up of Randomized Groups.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140550
- By:
- Publication type:
- Article
Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055807
- By:
- Publication type:
- Article
Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial.
- Published in:
- European Heart Journal, 2024, v. 45, n. 13, p. 1159, doi. 10.1093/eurheartj/ehad814
- By:
- Publication type:
- Article
Chronotherapy in hypertension: the devil is in the details.
- Published in:
- European Heart Journal, 2020, v. 41, n. 16, p. 1606, doi. 10.1093/eurheartj/ehaa265
- By:
- Publication type:
- Article
Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
- Published in:
- European Heart Journal, 2019, v. 40, n. 34, p. 2899, doi. 10.1093/eurheartj/ehy839
- By:
- Publication type:
- Article
May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension.
- Published in:
- European Heart Journal, 2019, v. 40, n. 25, p. 2006, doi. 10.1093/eurheartj/ehz300
- By:
- Publication type:
- Article
Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial.
- Published in:
- European Heart Journal, 2012, v. 33, n. 4, p. 486
- By:
- Publication type:
- Article
The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK.
- Published in:
- European Heart Journal, 2011, v. 32, n. 20, p. 2525, doi. 10.1093/eurheartj/ehr333
- By:
- Publication type:
- Article
Tissue Doppler E/E′ ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy.
- Published in:
- European Heart Journal, 2010, v. 31, n. 6, p. 747
- By:
- Publication type:
- Article
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.
- Published in:
- European Heart Journal, 2006, v. 27, n. 24, p. 2982
- By:
- Publication type:
- Article
Are current therapies for hypertension achieving their goal?
- Published in:
- Journal of the Renin-Angiotensin-Aldosterone System, 2006, v. 7, n. 2S, p. S3, doi. 10.3317/jraas.2006.034
- By:
- Publication type:
- Article
Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. A mini-symposium held at the British Hypertension Society Meeting, September 2005.
- Published in:
- 2006
- By:
- Publication type:
- research
Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers.
- Published in:
- Journal of the Renin-Angiotensin-Aldosterone System, 2006, v. 7, n. 2, p. 104, doi. 10.3317/jraas.2006.008
- By:
- Publication type:
- Article
Comparison of the effects of antihypertensive treatment with angiotensin II blockade and beta-blockade on carotid wall structure and haemodynamics: protocol and baseline demographics.
- Published in:
- Journal of the Renin-Angiotensin-Aldosterone System, 2002, v. 3, n. 2, p. 116, doi. 10.3317/jraas.2002.012
- By:
- Publication type:
- Article
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0574-y
- By:
- Publication type:
- Article
Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE‑ON study.
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0446-x
- By:
- Publication type:
- Article
The factors influencing clinician use of hypertension guidelines in different resource settings: a qualitative study investigating clinicians' perspectives and experiences.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Ethnic Differences in Blood Pressure Response to First and Second-Line Antihypertensive Therapies in Patients Randomized in the ASCOT Trial.
- Published in:
- American Journal of Hypertension, 2010, v. 23, n. 9, p. 1023, doi. 10.1038/ajh.2010.105
- By:
- Publication type:
- Article
Improving the Prognosis in Patients With Diabetes: What Will ADVANCE Tell Us?
- Published in:
- American Journal of Hypertension, 2007, v. 20, p. S19, doi. 10.1016/j.amjhyper.2007.04.006
- By:
- Publication type:
- Article
Children in South Asia have higher body mass adjusted blood pressure levels than Caucasian children in the United States -a comparative study
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Birthweight and blood pressure in children: Does the association exists?
- Published in:
- 2003
- By:
- Publication type:
- Abstract
Hypertension treatment and control. a systematic review across 3 regions and development of standardized criteria for assessment, analysis and reporting of data
- Published in:
- 2002
- By:
- Publication type:
- Abstract
Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT): blood pressure changes at 2.5 years of follow-up
- Published in:
- 2002
- By:
- Publication type:
- Abstract
Who should have their cholesterol measured? A comparison of selective cholesterol screening methods
- Published in:
- 2002
- By:
- Publication type:
- Abstract
Doxazosin for the management of hypertension: Implications of the findings of the ALLHAT trial.
- Published in:
- American Journal of Hypertension, 2001, v. 14, n. 11, p. 1170, doi. 10.1016/S0895-7061(01)02212-9
- By:
- Publication type:
- Article